Back to All Events

Cellular, Tissue, and Gene Therapies Advisory Committee

  • IQVIA Solutions Denmark A/S Denmark (map)

The Cellular, Tissue and Gene Therapies Advisory Committee (CTGTAC) on Thursday, June 9th (day 1) will review a Biologic license application (BLA) submitted by Bluebird Bio namely, BLA 125755 for elivaldogene autotemcel for the treatment of patients less than 18 years of age with early cerebral adrenoleukodystrophy.

Source:: https://www.fda.gov/advisory-committees/advisory-committee-calendar/cellular-tissue-and-gene-therapies-advisory-committee-june-9-10-2022-meeting-announcement-06092022
Earlier Event: June 8
Pharmacy Compounding Advisory Committee
Later Event: June 10
The Cellular, Tissue and Gene Therapies Advisory Committee